Neutrogena is facing renewed boycott calls after the death of actor Hayden Panettiere revived allegations about the end of her decade-long relationship with the skincare brand.
Hayden Panettiere had said that Neutrogena wanted to terminate her endorsement after she spoke publicly about postpartum depression in 2015.
Her account has since spread across social media, prompting criticism of the brand. However, the allegation has not been independently established by Neutrogena or through public contractual records.
What Panettiere Said Happened
Panettiere became associated with Neutrogena during her teenage years and said on the May 11, 2026 episode of Jay Shetty’s On Purpose podcast that she had worked with the company for about 10 years.
The dispute centres on comments she made publicly in September 2015, after giving birth to her daughter in December 2014. During an appearance on Live! With Kelly and Michael, Panettiere discussed experiencing postpartum depression and said the condition was misunderstood and that women needed support.
In her memoir, This Is Me: A Reckoning, published in May 2026, Panettiere wrote that Neutrogena subsequently cancelled her long-standing contract. She gave a more detailed version of the episode during her interview with Shetty, saying the brand had morality clauses in its agreement and that she received a call saying Neutrogena wanted to fire her because of the discussion.
Panettiere said her representative objected, arguing that the company could not terminate her for that reason. She said the contract continued for the remainder of its term, but she was not invited back the following year.
These details are important because they are based on Panettiere’s own account. There is no public evidence establishing that Neutrogena officially confirmed her version of events.
Why Boycott Calls Returned
The controversy resurfaced after Panettiere died on August 16, 2026, aged 36. Reuters reported that she was found unresponsive in Greenville, South Carolina, and that police did not suspect foul play. The cause of death remained under investigation.
Her death prompted renewed discussion of her earlier comments about Neutrogena, with social-media users calling for boycotts of the brand.
Several media outlets have reported the online backlash, but social-media posts and calls for a boycott do not establish that a large number of consumers have actually stopped purchasing Neutrogena products.
Reputation Risk Matters
The dispute illustrates a broader challenge for companies using celebrity ambassadors. Long-running partnerships can create strong associations between a brand and an individual’s public identity. When a former ambassador later describes the relationship negatively, an old contractual decision can become a new reputational issue.
The sensitivity is heightened here because Panettiere’s account involved postpartum depression, a subject she had discussed publicly in an effort to reduce stigma around maternal mental health.
For Neutrogena, the central issue is therefore not simply whether online boycott calls translate into lost sales. It is whether consumers interpret the company’s reported handling of a former ambassador’s mental-health disclosure as inconsistent with their expectations of a modern healthcare and beauty brand.
At present, the evidence supports saying that Neutrogena faces online backlash and boycott calls. It does not support claiming a confirmed consumer boycott, a specific revenue loss or a financial hit caused by Panettiere’s death.
Also Read: Trump Declares ‘Economic D-Day’ on Iran, Warns Its Backers of ‘Tremendous Economic Consequences’
